Q3 2024 Medistim ASA Earnings Call Transcript

Author's Avatar
Oct 24, 2024

Oct 24, 2024 / 07:00AM GMT
Kari Krogstad - Medistim ASA - President, Chief Executive Officer

Good morning, everyone, and welcome to Medistim's Third Quarter and Year-to-Date September Financial Results Presentation. So, my name is Kari Krogstad and together with CFO, Thomas Jakobsen, we will be very happy to take you through the results.

And just before we get started here, just want to remind everyone of our track record and our ambition, which is to continue to deliver profitable growth as we've seen that we've done in the past. So with a growth in sales of around 10% annually.

But let's look at the third quarter results. So in this third quarter, we are delivering 7% growth in Norwegian currency. And taking into account the currency effect here, we see a total sales growth of 5.3%. So this means that sales growth has been gradually increasing during the first quarter this year, both in Norwegian currency and currency neutral.

But the most encouraging development this quarter is the robust recovery from our Americas sales region. So we can see that Americas is up by 17.3% currency neutral this quarter.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot